Inventor

MICHAELS MARK LEO

US20 patents

⚠️ This page may combine multiple inventors who share the name “MICHAELS MARK LEO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MICHAELS MARK LEO

AMGEN INC

FGF21 polypeptides comprising two or more mutations

Uses of FGF21 polypeptides comprising two or more mutations

FGF mutants with reduced proteolysis and aggregation

Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

Methods of treating of diabetes and obesity using FGF21 mutants

FGF21 mutants comprising a mutation at position 98, 171 and/or 180

Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereof

Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

Stabilized receptor polypeptides and uses thereof

Variants of tissue inhibitor of metalloproteinase type three (TIMP-3), compositions and methods

Inhibitory polypeptides specific to WNT inhibitors

BELOUSKI EDWARD JOHN

FGF21 polypeptides comprising two or more mutations and uses thereof

FGF 21 polypeptides comprising two or more mutations and uses thereof

FGF21 mutant fusion polypeptides and uses thereof

FGF21 mutants multimers and uses thereof

FGF21 mutants and uses thereof

FGF21 mutants and uses thereof

SUN JEONGHOON

Stabilized activin IIB receptor polypeptides and uses thereof

AMGEN

Stabilized receptor polypeptides and uses thereof

FACHINI ROGER

Human FGF receptor and β-Klotho binding proteins